Related Experiment Videos
Distinguished Scientists Lecture Series. New developments in kidney development
1George M. O'Brien Kidney and Urological Disease Center, Renal Division, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA. mhammerm@imgate.wustl.edu
Background/Aims:
The number of kidney transplantations performed per year is limited due to the availability of donor organs. One possible solution to the organ shortage is the use of renal xenografts. However, the transplantation of xenografts is complicated by rejection.
Methods:
It has been postulated that the host immune response might be attenuated following the transplantation of embryonic kidneys (metanephroi) rather than developed (adult kidneys). Transplanted metanephroi become chimeric organs in that their blood supply originates from the host. It is possible to transplant a developing metanephros, without the use of immunosuppression, from one outbred rat to another.
Results:
Transplanted metanephroi grow, develop, become vascularized, and function in host rats. In contrast, developed adult kidneys transplanted from one rat to another undergo rejection within 7 days after transplantation.
Conclusions:
These observations suggest that metanephric tissue may be less immunogenic than adult kidney. Transplantation of metanephroi represents a new development that could lead to a novel therapeutic approach to the treatment of chronic renal failure.
Insights
Transplanting embryonic kidneys (metanephroi) into rats showed reduced immune rejection compared to adult kidneys. This suggests metanephroi could be a viable alternative for treating kidney failure.
Area of Science:
- Nephrology
- Transplantation immunology
- Developmental biology
Background:
- Kidney transplantation is limited by donor organ availability.
- Renal xenografts are a potential solution but face immune rejection challenges.
- Embryonic kidneys (metanephroi) may elicit a reduced host immune response compared to adult kidneys.
Discussion:
- Transplanted metanephroi integrate as chimeric organs, utilizing the host's vasculature.
- This integration occurs without the need for immunosuppression in rat models.
- Adult kidney grafts, conversely, experience rapid rejection within seven days.
Key Insights:
- Metanephric tissue demonstrates lower immunogenicity than developed adult kidney tissue.
- Successful vascularization, growth, and function of transplanted metanephroi were observed.
- Metanephroi transplantation bypasses the typical rejection pathways seen with adult organs.
Outlook:
- Metanephroi transplantation offers a novel therapeutic strategy for chronic renal failure.
- Further research into metanephric tissue immunomodulation could advance xenotransplantation.
- This approach may reduce reliance on immunosuppressive drugs in kidney replacement therapy.